Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Acknowledgment

Acknowledgment Am J Cancer 2005; 4 (6): 347-348 ACKNOWLEDGMENT 1175-6357/05/0006-0347/$34.95/0 © 2005 Adis Data Information BV. All rights reserved. Dear Readers, We hope that you have enjoyed the articles published in the American Journal of Cancer in 2005. We are pleased to have been able to provide such varied and topical articles. The forward program for 2006 looks set to ensure the provision of similarly up-to-date and high- interest articles, including the following: Cost Considerations for Monoclonal Antibody Targeted Therapy in Cancer. Vascular Targeting and Therapeutics for Head and Neck Cancer. Gene Transfer Therapy in Cancer. Management Strategies for Relapsed Multiple Myeloma. Biomarkers for Development of Cancer Vaccines. Epidermal Growth Factor Receptor Antagonists in Pancreatic Cancer. Clinical Application of Proteomics in Cancer Prevention and Treatment. As always, we would be pleased to consider any high-quality review and original research articles that you care to submit to us to supplement our program of invited articles. We would like to take this opportunity to thank all of the authors who have contributed articles to the American Journal of Cancer during the past 12 months. They have generously set aside time in their busy schedules to prepare articles for the journal, and their http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Acknowledgment

American Journal of Cancer , Volume 4 (6) – Aug 9, 2012

Loading next page...
 
/lp/springer-journals/acknowledgment-4zI9uq0ciQ

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2005 by Adis Data Information BV
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200504060-00001
Publisher site
See Article on Publisher Site

Abstract

Am J Cancer 2005; 4 (6): 347-348 ACKNOWLEDGMENT 1175-6357/05/0006-0347/$34.95/0 © 2005 Adis Data Information BV. All rights reserved. Dear Readers, We hope that you have enjoyed the articles published in the American Journal of Cancer in 2005. We are pleased to have been able to provide such varied and topical articles. The forward program for 2006 looks set to ensure the provision of similarly up-to-date and high- interest articles, including the following: Cost Considerations for Monoclonal Antibody Targeted Therapy in Cancer. Vascular Targeting and Therapeutics for Head and Neck Cancer. Gene Transfer Therapy in Cancer. Management Strategies for Relapsed Multiple Myeloma. Biomarkers for Development of Cancer Vaccines. Epidermal Growth Factor Receptor Antagonists in Pancreatic Cancer. Clinical Application of Proteomics in Cancer Prevention and Treatment. As always, we would be pleased to consider any high-quality review and original research articles that you care to submit to us to supplement our program of invited articles. We would like to take this opportunity to thank all of the authors who have contributed articles to the American Journal of Cancer during the past 12 months. They have generously set aside time in their busy schedules to prepare articles for the journal, and their

Journal

American Journal of CancerSpringer Journals

Published: Aug 9, 2012

There are no references for this article.